Intended for healthcare professionals

Rapid response to:

Analysis

Overspending driven by oversized single dose vials of cancer drugs

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i788 (Published 01 March 2016) Cite this as: BMJ 2016;352:i788

Rapid Response:

Re: Overspending driven by oversized single dose vials of cancer drugs

I suspect the cost savings proposed here are grossly overstated due to the simple fact that the cost to manufacture the drugs is essentially unrelated to the cost of the drug. The drug companies are selling their intellectual property and pricing the drugs to provide a certain number of treatments based on what the market will bear. This is a cute paper, but the prices for the treatments would simply rise in the years it would take to establish systems to reduce waste. Waste should be reduced when possible but this article is hyperbole.

Competing interests: No competing interests

01 March 2016
Branden Tarlow
Medical student
3181 SW SAM JACKSON PK RD, Portland, Oregon